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The monoclonal antibody technique is providing new reagents for the study
of mononuclear phagocytes. Among other applications, specific antibodies should
make it possible to distinguish macrophages from other cell types in suspension
and tissue sections. This potential has not been fully exploited, since the number
of specific, panmacrophage reagents is limited. In mouse, a single monoclonal
antibody, F4/80, appears to be truly macrophage restricted (1, 2). In rat, guinea
pig, and rabbit, macrophage-specific reagents have yet to be described to our
knowledge. In man, several antimonocyte antibodies have been produced (310). However, there has been little work using these reagents to distinguish
macrophages from dendritic cells and to visualize macrophages in tissue sections.
The distinction between macrophages and dendritic cells is critical, since the
two cell types differ so markedly in functional capacities. The dendritic cell lacks
Fc receptors (2, 1 1, 12), does not exhibit active phagocytic or pinocytic activity
(1 1), but is the principal accessory cell needed to stimulate lymphocyte responses
(see 13). Recently it has been shown that enriched populations of dendritic cells
from human blood are markedly more potent than monocytes in stimulating
mixed leukocyte reactions and polyclonai T cell mitogenesis (14, 15).
Here we describe monocional antibodies directed to an antigen that is restricted to mononuclear phagocytes including monocytes in blood and macrophages in lung, skin, spleen, and lymph node. We then use the monoclonals in
two types of experiments to further characterize human mononuclear phagocytes
and dendritic cells. First, depletion of monocytes with antibody and complement
can be used to prepare circulating dendritic cells in high purity and yield. Second,
the monoclonals stain macrophages in tissue sections, localizing this cell type to
the dermis of skin, red pulp of spleen, and lymphatic channels of lymph node.
In contrast, presumptive dendritic cells are localized in entirely different anatomic regions: skin epidermis, splenic white pulp, and lymph node cortex.
Therefore these monoclonal antibodies provide a clear distinction between
macrophages and dendritic cells in blood and tissues.
* Supported by grant CA 30198 from the National Institutesof Health.
Established Investigatorof the AmericanHeart Association.
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Materials and Methods
Blood was obtained from normal volunteers, and leukocyte-enriched buffy coats
were purchased from the Greater New York Blood Center. Mononuclear ceils were
harvested from the interface of Ficoll-Hypaque (density = 1.077; Histopaque 1077-1;
Sigma Chemical Co., St. Louis, MO) columns and cultured for 1-2 h on 100-mm plastic
culture dishes. The medium was 5% heat-inactivated fetal calf serum (FCS) 1 (Sterile
Systems, Logan, UT, and Kansas City Biologicals, Kansas City, MO)-RPMI 1640 (Grand
Island Biological Co., Grand Island, NY) supplemented with 20 ttg/ml gentamycin, 100
U/ml penicillin, 1 mM glutamine, and 5 x 10 -5 M 2-mercaptoethanol. Nonadherent cells
(~70% of the total) were removed with several washes and used to prepare T cells by
rosetting with neuraminidase-treated sheep erythrocytes or by nylon wool filtration (14).
Adherent cells were cultured overnight and separated into monocyte-, B cell-, and
dendritic cell-enriched fractions as described (14). T lymphoblasts were prepared by
stimulating nonadherent cells with 2 ug/ml phytohemagglutinin (Burroughs Wellcome &
Co., Greenville, NC) for 4 d in 5% FCS-RPMI 1640 medium. B lymphoblasts were
prepared by stimulating high density B cell-enriched fractions (14) with 3 #g/ml pokeweed
mitogen (Difco Laboratories Inc., Detroit, MI) for 4 d in 5% FCS-RPMI-1640 medium.
Granulocytes were kindly provided by Dr. H. B. Fleit (The Rockefeller University) who
sedimented the granulocytes through Ficoli-Hypaque, removed most erythrocytes by
dextran sedimentation, and depleted residual erythrocytes by hypotonic lysis (16). Platelets
were present in mononuclear cell fractions and could be isolated because they did not
pellet at 180 g for 10 rain. To study the stability of cell surface antigens in culture,
monocyte-enriched fractions were maintained for I-3 wk either adherent to glass coverslips in 10% AB+ human serum-RPMI 1640, in plastic culture dishes in 5% FCS-RPMI
1640, or in teflon beakers as described (17; kindly provided by Dr. S. B. Wright). The
cultured cells were >98% viable monocytes by morphology, nonspecific esterase reactivity,
and binding of specific monoclonal antibodies. Dr. A. Fels and Dr. T. Nash (The
Rockefeller University) provided alveolar macrophages by bronchial lavage of nonsmokers, followed by collection of mononuclear cells on Ficoll-Hypaque columns, and adherence to glass coverslips (18). Several human cell lines were provided by Dr. J. C. Unkeless
(The Rockefeller University) and Dr. H. B. Fleit: HL60 (promyelocyte-like), K562
(multipotential blood cell precursor), U937 (immature myeloid), and Daudi (B cell).
Several human lymphocyte lines were provided by Dr. L. Mayer (The Rockefeller
University): T cell lines CEM T and Jurkat, and B cell lines SeHa D, 8866P, and 32al.
M o n o d o n a l Antibodies. A large panel of mouse anti-human monoclonal antibodies
(Table I) was produced in our lab and obtained from outside sources. For the new reagents
(3C10, 1D9, 1E8), a BALB/c mouse (The Trudeau Institute, Saranac Lake, NY) was
injected intraperitoneally with 108 blood monocytes in saline three times at monthly
intervals, and four times with 3-5 x 108 monocytes on each of the 4 d before fusion (19).
For 9.3F10, which recognizes Ia-like or class II major histocompatibility products (see
Results), exactly the same protocol was used except that dendritic cell-enriched (14)
preparations were injected into mice. Spleen cells from these mice were fused to P3U 1
myeloma cells at a ratio of one myeloma cell to five spleen cells as described (20). The
products of these fusions were seeded at 5 X 104 myeloma cells per 0.32-ram 2 microwell
(3596; Costar, Cambridge, MA) with 100 /A of hypoxanthine-aminopterine-thymidine
(HAT) culture medium (Dulbecco's minimal essential medium, supplemented with HAT,
horse serum, FCS, vitamins, and NCTC 109 medium as described [20]).
The immunization method of Staehli (19) that we used provided a large number of
hybrids reactive with human leukocytes, so that a rapid radioimmunoassay was used to
detect antibodies of interest. A large panel of test cells and cell lines (see above) were
attached tc Terasaki microassay plates (3034; Falcon Labware, Oxnard, CA) that had
been exposed to 100 ug/ml poly-L-lysine (70,000 average tool wt; P2636; Sigma Chemical
Co.) in phosphate-buffered saline (PBS) for 20 min, rinsed in distilled water and dried.
l Abbreviations used in this paper: FCS, fetal calf serum; HAT, hypoxanthine-aminopterin-thymidine; PBS, phosphate-buffered saline; SDS-PAGE, sodium dodecyl sulfate-polyacrylamidegel electrophoresis.
Cells.
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TABLE I

Monoclonal Mouse Antihuman Leukocyte Antibodies
Molecular
weight of
polypeptide

Ig subclass

Source

T29/33

lgG2b

Dr. I. S. Trowbridge,
Salk Inst., CA

200,000

OKlal

IgG2~

34,000,
29,000

OKMI

lgGeb

Ortho Diagnostic Systerns Inc., Westwood, MA
Ortho Diagnostic Systerns Inc.

63D3

lgG~

61 D2

IgG2a

Leu 1

IgG2a

3G8

IgG1

1B4

IgG2a

BA-I

IgM

OKT6

lgGi

1D9
3C 10
1E8
9.3F10

170,000

Bethesda Research
Laboratories,
Gaithersburg, MD
Bethesda Research
Laboratories
Becton, Dickinson &
Co., Oxnard, CA
Dr. H. B. Fleit, The
Rockefeller Univ.

200,000

182,000,
123,000,
105,000
NA

IgGl
lgG2b
IgG~

Dr. S. D. Wright,
The Rockefeller
Univ.
Hybritech, Inc., San
Diego, CA
Ortho Diagnostic Systerns Inc.
Authors
Authors
Authors

IgG~a

Authors

Specificity
All leukocytes (Leukocyte-common
Ag)
HLA-class II Ag
Monocytes, natural
killer cells granulocytes, T3'
Monocytes, granulocytes

Reference
21
22
3
4

44,000

HLA-class I Ag

67,000

All T cells

66,000,
53,000

Anti-Fc 3' receptor
16
on human leukocytes
Complement recep- In preparation
tor (C3bl)on human leukocytes
B cells, granulocytes
24

52,000
55,000
55,000
ND
29,000,
33,000

Thymocytes, Langerhans' cells
Monocytes
Monocytes
Monocytes, granulocytes
HLA-class II Ag

4
23

25
This paper
This paper
This paper
This paper

1-4 x 10 4 cells in 5 - 1 0 #1 of RPMI 1640 with 0.02% NaNs (azine) were a d d e d to each
well. T h e plate was centrifuged at 150 g for 5 min at 4°C and quenched in cold RPMI
1640 with 10% horse serum and azide. After 20 rain, the fluid was aspirated and 10 t~l of
culture supernatant was a d d e d for 1 h on ice. T h e plates were rinsed by dipping in cold
PBS with azide, aspirated, and exposed to 10 #1 of 5 # g / m l 125I-F(ab')~ affinity-purified
rabbit anti-mouse lgG (specific activity o f 6 X l 0 s c p m / # g ) in RPMI 1640 with 10% horse
serum and azide on ice for 30 min. Finally the plates were rinsed, dried, and autoradiographed for 3 - 2 4 h at - 7 0 ° C using Kodak XAR5 film (Eastman Kodak Co., Rochester,
NY) and an intensifying screen (Lightening Plus; Dupont Co., Wilmington, DE).
Using this technique, we noted that hybrid wells 3C 10 and 1D9 reacted with monocytes
alone; 1E8 with monocytes, granulocytes, and the U937 and HL60 cell lines; and the
commercially available reagent O K M I with granulocytes and monocytes. In a similar
assay, 3C10, 1 D9, and 1E8 did not show detectable binding to B cells, T cells, dendritic
cells, and three B cell and two T cell lines, suggesting that the reagents were specific for
myeloid elements. In contrast, 9.3F10 reacted with monocytes, B cells, dendritic cells,
and three B cell lines, but not with granulocytes, T cells, two T cell lines, and the U937,
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FIGURE 1. Analysisof 3C10 and 9.3F10 Ig and Fab fragments. One-dimensional 11% SDSPAGE was run under reducing conditions and stained with Coomassie brilliant blue. 3C10 is
antimonocyte and 9.3F10 is an anti-HLA class II. For each antibody, samples were analyzed
from the purified Ig fraction (ascites passed over diethylaminoethylcellulose), the papain (Pap)
digests, and the Fab fragments purified from the digests. Std, standard.
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HL60, and K562 cell lines, indicating it was an anti-Ia or anti-class II reagent. Many
additional hybrids were identified with similar reactivity patterns to 3C 10, I D9, 1E8, or
9.3F10. The latter were cloned in soft agar, and further characterized as described in
Results. All hybridoma clones produced an Ig-rich ascites in DBA/2 X BALB/c F~ mice.
Purification and Radiolabeling of Monoclonal Antibodies. Monoclonal antibodies 3C10,
1Dg, 1E8, and 9.3F10 were purified from ascites using 45% (vol/vol) (NH4)2804 precipitation followed by ion exchange chromatography on diethylaminoethyl cellulose (DE-52;
Whatman Inc., Clifton, NJ). The Ig fraction gave a single band on cellulose acetate
electrophoresis that co-migrated with the monoclonal band in the unseparated ascites.
The subclass of the purified antibody was determined by Ouchterlony analysis using
subclass-specific antisera prepared in goats (Meloy Laboratories Inc., Springfield, VA) and
the results are presented in Table I. T o prepare active (see Results) Fab fragments of the
3C10 antimonocyte and 9.3F10 anti-class II antibodies, Ig at 8 m g / m l and 5 mg/ml,
respectively, was digested with 1% (wt/wt) papain (P-4762; Sigma Chemical Co.) in pH
5.5 0.1 M sodium acetate buffer with 2 mM EDTA and 10 mM 2-mercaptoethanol for 4
h at 37°C. The reaction was stopped by bringing the solution to 20 mM iodoacetamide.
The mixtures were dialyzed into 25 mM Tris pH 8.0 and passed over DE-52. Following
electrophoresis on 11% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDSPAGE) (26) under reducing conditions, the papain digests contained four to five polypeptides, including the candidate Fc, Fd, and light chain portions; the flow-through fractions
were the presumptive Fab fragments with only two bands (Fig. 1). The intact antibodies
and digests reacted with subclass-specific antisera, but the flow-through Fab fractions did
not; all reacted with rabbit anti-mouse IgG (heavy and light chains).
Antibodies were labeled with Na-~25I (carrier-free; New England Nuclear, Boston, MA)
using lodo-Gen (Pierce Chemical Co., Rockford, IL) as the oxidizing agent (27) as
described (2). The iodinated and noniodinated antibodies competed for binding to
monocytes with equal efficiency (see Results).
Binding of Monoclonal Antibodies to Cells In Vitro. Indirect immunofluorescence was done
using a sensitive biotin-avidin system as described (14). Briefly, cells were exposed
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successively to: (a) mouse anti-human monocional antibody, (b) biotinylated horse antimouse Ig (Vector Laboratories Inc., Burlingame, CA), and (c) fluorescein-avidin (Vector
Laboratories Inc.). Biotinylated horse anti-human Ig (Vector Laboratories Inc.) was used
at 20 #g/ml to stain B cells.
Quantitative binding studies with monoclonal antibodies were performed at 4°C with
cells attached to 16-mm poly-L-iysine-coated macrowells (3524; Costar) as described above
for the screening radioimmunoassay, except that the volume of the well was always
maintained at 0.25 ml; 1-4 × 105 cells were used per well; and the bound radioactivity
was determined by wiping the cells with cotton swabs and counting these in a Packard
gamma counter (Packard Instrument Co., Downers Grove, IL). Additional details are
provided in the legends to Tables IV-V.
Quantitative binding studies were used to monitor the effect of protease treatment on
monocyte-specific and class II antigens. Treatment with proteases was done in suspension
at 5 × 106 cells/mi in PBS with 1 m g / m i of either TPCK-trypsin (T8642), chymotrypsin
(C4129; Sigma Chemical Co.), or pronase (53702; Calbiocbem-Behring Corp., La Jolla,
CA) for 15 min at,37°C; or by 0.1 I U / m l neuraminidase (vibrio cholerae; 480717;
Calbiochem-Behring Corp.) for 45 min at 37°C. Viability was >90% by trypan blue
exclusion after each treatment. Cells were then centrifuged onto poly-L-iysine-coated 16mm wells at 4 × 105 cells per well, and the amount of antigen was quantified as above.
Ident~cation of the Polypeptide Carrying the 3C10/1D9 Monocyte Antigen. The "western
blot" procedure was modified slightly from those described by Towbin et al. (28) and
Johnson et al. (29). In brief, 5 × 10 6 adherent cells were soluhilized in lysis buffer, i.e.,
PBS with 0.5% NP40 detergent, 0.2 trypsin inhibitory units trasylol (aprotinin; A-6012)
and 2 mM phenylmethylsulfonylfluoride (P-7626; Sigma Chemical Co.). The lysate was
cleared by centrifugation at 600 g for 10 min, and then 20,000 g for 20 min. The iysate
was mixed 1:1 with sample buffer (4% SDS, 24% sucrose, 0.05% bromphenol blue, 100
mM Na2CO3, pH 8.5), boiled for 2 min, and electrophoresed 10 cm on a 1-mm, 4-11%
gradient SDS-PAGE. The proteins were transferred from the gel lane onto nitrocellulose
(BA85; Schleicher & Schuell, Inc., Keene, NH) by electrophoresis. The nitrocellulose
filter was incubated for 16 h with PBS-Tween (10% horse serum, 0.1% gelatin, 0.1%
NaNa, 0.05% Tween 20 in PBS), which served as both wash and carrier buffer for all
incubations. The filter was exposed at 4°C for 20 h to either directly 125I-labeled
monoclonal antibody or unlabeled monoclonal antibody (sandwich assay), washed four
times over 45 rain at room temperature and, for the sandwich assay, exposed to 125IF(ab')2 rabbit anti-mouse Ig at 4°C for 20 h. The blot was then washed extensively and
autoradiographed for 16-48 h as above.
The immunoprecipitation procedure was carried out on overnight-cultured, adherent
mononuclear cells that were surface labeled with '25I and iactoperoxidase/glucose oxidase
(30). The cells were solubilized and cleared by centrifugation as described above. Then
SDS was added to a final concentration of 0.2%, and the lysate was preabsorbed for 1 h
at 4°C with 100 /agm crude mouse immunoglobulin (45% (NH4)~SO4 precipitate of
nonimmune mouse serum) coupled to Sepharose 4B (Pharmacia Fine Chemicals, Piscataway, NJ), per 106 cell equivalents. The supernatant representing 106 cell equivalents was
then absorbed with 100 #gm of antibody coupled to Sepharose 4B for 1 h at 4°C. The
beads were washed three times in lysis buffer with 2% FCS and two times in lysis buffer
alone. The antigen was released by boiling with sample buffer and 50 mM dithiothreitol
and electrophoresed for 20 cm. The gel was dried and autoradiographed for 7 d.
Complement-mediated Cytotoxicity. Killing with antibody and rabbit complement was
accomplished by exposing cells (1.7-2.5 x 106 cells/ml) to antibody (3C10 antimonocyte
at I0 #g/ml; 9.3F10 anti-Ia at 3/zg/ml; Leu-1 anti-T cell at 3 gg/ml; BA-1 anti-B cell at
3 #g/mi) and rabbit serum (selected for low background cytotoxicity and stored at - 7 0 °C
after lyophilization; 1:9 final dilution) for 1 h at 37°C. All reagents were diluted in 0.3%
bovine serum albumin, 25 mM Hepes, RPMI 1640 pH 7.4, and deoxyribonuclease
(DNAase I; Sigma Chemical Co.) was present at 10 t~g/ml. The percentage killed was
determined by the reduction of viable cells (trypan blue exclusion test) as compared with
the mean of the control incubations; i.e., no treatment, heated (56°C for 30 min)
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Results
T h e purpose o f this study was to develop monoclonai antibodies that reacted
only with m o n o n u c l e a r phagocytes in blood and in tissues, and not with dendritic
cells. T h e monocionais could then be used to help purify dendritic cells from
blood and to show that macrophages and dendritic cells occupy distinct anatomic
c o m p a r t m e n t s in spleen, lymph node, and skin.
Cell Specificity of 3ClO, ID9, and 9.3F10 Monoclonal Antibodies. Initial screening
with a microradioimmunoassay (see Materials and Methods) indicated that 3C 10
and 1 D9 reacted with monocytes, whereas 9.3F10 reacted with many cell types
and lines known to express class II H L A products. After cloning, we evaluated
culture supernatants, purified Ig, and Fab fragments, for reactivity with a large
panel o f cell types using immunofluorescence and a sensitive biotin-avidin technique. 3C 10 and 1 D9 stained monocytes strongly, but did not react with a large
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complement alone, active complement alone, and heated complement plus antibody. The
standard error of the averaged controls was <10%. The percentage of monocytes was
monitored by staining cytocentrifuge preparations with a-naphthyibutyrate for nonspecific
esterase according to the method of Li et al. (31). Cells with diffuse red cytoplasmic
staining were scored as monocytes. Staining for myeloperoxidase, with diaminobenzidine
tetrahydrochioride and hydrogen peroxide (32), was also used to count monocytes with
similar results. However the percentage of monocytes that were peroxidase positive
diminished to ~ 50% after overnight culture.
Dendritic Cell Purification with Cytotoxic Cell-specific Antibodies. To enrich for dendritic
cells using cell-specific antibodies, we began by treating 0.5-5 × 108 blood mononuclear
cells with 3C 10 antimonocyte antibody and complement, or complement alone as outlined
above. The cells were washed and adhered in 100-mm plastic culture dishes for 1 h at
37°C in 5% FCS medium. The nonadherent cells were removed with five rinses and the
adherent monolayers were cultured for 18 h. Most of the adherent cells had released
from the plastic, and these were retreated with 3C10 as well as BA-1 and Leu-1 (anti-B
and -T cell, respectively) antibodies and complement, or just complement for the control
cells. Almost all of the viable cells (~80%) were retrieved by flotation in columns of dense
bovine plasma albumin (P = 1.082) as described (14). This fraction was highly enriched
for dendritic cells (see Results). An alternative approach to eliminate monocytes was to
treat mononuclear cells with 3C10 antibody and complement after, rather than before,
adherence to plastic. The former requires less complement, but the latter approach was
used in this paper to establish that normal numbers of dendritic cells adhere to plastic
after elimination of most monocytes.
Staining Tissue Sections with Monoclonal Antibodies. Skin biopsies were obtained by Dr.
W. R. Levis (The Rockefeller University) from patients with leprosy, but normal skin
samples were also stained. Spleen and lymph node were provided by the Tumor Procurement Center of Memorial Sloan-Kettering Cancer Center, New York. The tissues, which
did not contain tumor cells, were frozen in liquid nitrogen, embedded in OCT embedding
medium (Lab-Tek Div., Miles Laboratories Inc., Naperviile, IL), sectioned at 6-8 #m
with a cryostat, and stored at -20°C. The sections were fixed before staining for 30 s
with ice-cold acetone. Immunoperoxidase staining was done as previously described for
immunofluorescence of tissue sections (33), except that after treatment of tissue sections
with monoclonal antibody and biotinylated horse-anti-mouse IgG, the sections were
treated with 20 #g/ml avidin-horseradish peroxidase (Vector Laboratories Inc.), and
developed with 0.4 mg/ml 3,3' diaminobenzidine tetrahydrochloride (Polysciences Inc.,
Warrington, PA) in 0.05 M Tris buffer, pH 7.6, with 0.01% HeO2 for 10 min at room
temperature. Sections were stained for 3 min with Gill's hemotoxylin (formulation 1;
Fisher Scientific Co., Fairlawn, NJ).
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TABLE II

Reactivity of Monoclonal Antibodies with Different Cell Types
Percentage of cells positive after staining with:
Cells
PBMC* 1
PBMC 2
Monocytes
Granulocytes
Dendritic cells
T Cells (E,+)
T lymphoblasts
Non-T ( E , - )
B cells
B lymphoblasts
Erythrocytes
Platelets
45-d cultured monocytes
Alveolar macrophages

3C10

9.3F10

OKIa

Leu-1

Anti-Human Ig

Anti-HLA
class I

Percent
monocytes

30
25
95
<1
10
1
1
4
2
1
0
0
100
98

28
23
78
<1
100
5
7
37
84
84
0
0
100
99

26
24
78
<1
100
5
7
33
81
82
0
0
ND
ND

60
53
1
ND
6
95
85
8
19
21
0
0
0
0

7
14
2
<1
44
2
1
24
78
68
0
0
ND
ND

100
100
100
100
100
100
100
100
100
100
ND
100
ND
ND

31
25
96
<1
10
1'
1
4*
2
1
0
0
100
98

Enriched populations of various cell types were prepared as described in Materials and Methods.
The dendritic cell-enriched fraction was 29% dendritic cells, 55% lymphocytes, and 10% monocytes
by morphology. The percent monocytes was generally determined by morphology, i.e., circumferential spreading, ruffles, large-phase dense lysosomal granules. ND, not done.
" Peripheral blood mononuclear cells.
* Percent monocytes determined by diffuse nonspecific esterase staining.
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panel of other cell types (Table II). A small percentage of cells were stained in
the B cell- and dendritic cell-enriched populations, but this percentage corresponded to the number of contaminating monocytes estimated by cytologic
criteria or by nonspecific esterase staining. 9.3F10 stained most monocytes, B
cells, and dendritic cells, but not T cells, platelets, and granulocytes (Table II).
9.3F 10 stained similarly to OKIa (22), further suggesting that it recognized class
II HLA antigens. The Fab fragments of 3C 10 and 9.3F 10 stained a similar panel
of cell types to the corresponding intact Ig (not shown). Leu-1 and anti-Ig reacted
with most cells in the T and B cell-enriched populations, respectively, but not
with monocytes, dendritic cells, and other cell types (Table II).
By indirect immunofluorescence, the 3C 10 antigen was stable in culture. Thus
3C10 was expressed on 95% of monocytes that had been cultured for 45 d in
teflon beakers to retard adherence (Table II). Glass-adherent monocytes were
3C10 + for 21 d, but at 28 d about 25% became 3C10-. The latter frequently
were multinucleated giant cells. Alveolar macrophages, obtained by bronchial
lavage, were all stained with 3C10 and 3C10 Fab fragment, but not with the T
lymphocyte specific marker, Leu-1 (Table II).
In the presence of rabbit complement, 3C10 killed >95% of purified monocytes but did not kill populations enriched in other cell types (not shown). 9.3F 10
killed 30-70% of monocytes, as well as most B cells and dendritic cells. 3C10
efficiently and selectively depleted monocytes from heterogeneous mixtures of
unfractionated mononuclear cells or plastic-adherent cells (Table III). Total cell
killing precisely paralleled the loss of cells that stained diffusely for nonspecific
esterase, an independent monocyte marker (Table III). >95% of the esterase-
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TABLE III

Summary of CytotoxicityExperiments with Antimonocyte and Anti-Ia Antibodies and Rabbit
Complement
Untreated
cells
Population

n

Peripheral blood
mononuclear cells

3C10
9.3F10

Adherent mononuclear
cells

3C10
9.3F10

Percent esterase÷

Percent
killed

Percent esterase ÷

11
4

31 + 8
31 + 9

27 + 9
20 ± 7

2± 1
14 ± 13

5
I

54 + 9
54

52 _ 6
65

2- 2
35

Unfractionated mononuclear cells or plastic-adherent cells (released after overnight culture) were
treated with antimonocyte (3C10) or anti-la (9.3F10) antibodies and rabbit complement. We then
counted the percent (mean + standard error) of cells that were stained diffusely for nonspecific
esterase in aliquots of untreated and antibody plus complement-treated cells. The percent killed was
determined by trypan blue staining.
TABLE IV

Number of 3ClO, 1D9 (Antimonocyte), and 9.3F10 (Anti-la) Binding Sites per Monocyte
~2sI-labeled antibody
3C10 (intact lg)
3C10 (Fab fragment)
1D9 (intact Ig)
9.3F10 (intact Ig)
9.3F 10 (Fab fragment)

ng of antibody bound per 4 X 105 monocytes
(molecules of antibody bound per monocyte)
Experiment A

Experiment B

Experiment C

3.6 (38,000)
1.3 (38,000)
3.4 (34,000)
23 (230,000)

4.9 (47,000)
1.5 (46,000)
-

1.0 (37,000)
7.5 (225,000)

In experiment A, saturating doses of ~2~I-antibody(3-12 t~g/ml) were added, while in experiment B,
a constant dose of ~5I-antibody (0.2 •g/ml for intact and 1.0 ~g/ml for Fab) was mixed with varying
doses of unlabeled antibody (0-12 t~g/ml for intact, 0-32 tag/ml for Fab). The values given are
means of at least three saturating doses, the standard deviation being <10%. Nanograms of antibody
bound was determined by: [(cpm bound - no-cell control)/specific activity of the antibody]. The nocell control was <2% of the total bound. 1 ng of intact Ig ( ~ 150 kD) was assumed to be 4.0 × 109
molecules and 1 ng Fab (~50 kD) 1.2 × 10 t° molecules. The monocytes were studied after 1 d of
culture.
p o s i t i v e cells w e r e k i l l e d a n d t h e p r e p a r a t i o n s r e m a i n e d m o n o c y t e d e p l e t e d f o r
> 1 w k in c u l t u r e . I n c o n t r a s t , t h e c y t o l y t i c anti-class I I r e a g e n t 9 . 3 F 1 0 d i d n o t
kill all t h e m o n o c y t e s j u d g e d to b e 9 . 3 F 1 0 r e a c t i v e b y i m m u n o f l u o r e s c e n c e
( T a b l e I I I ) . W e c o n c l u d e t h a t 3 C 1 0 a n d 1D9 r e c o g n i z e a n a n t i g e n t h a t is
m o n o n u c l e a r p h a g o c y t e specific a n d is p r e s e n t o n m o s t if n o t all f r e s h a n d
cultured monocytes and alveolar macrophages.
Quantitative Binding Studies. S a t u r a b l e b i n d i n g o f t h e a n t i m o n o c y t e a n d a n t i class II m o n o c l o n a l a n t i b o d i e s o c c u r r e d a t 0 . 3 - 1 . 0 # g / m l f o r 1 - 4 x 105 cells.
M o n o c y t e s e x p r e s s e d 3 . 7 - 4 . 7 x 104 b i n d i n g sites f o r 3C 10, 3 C 10 F a b , a n d 1 D9,
a n d 1 . 3 - 2 . 3 x 105 b i n d i n g sites f o r t h e anti-class I I r e a g e n t , 9 . 3 F 1 0 , a n d its F a b
f r a g m e n t (see T a b l e IV). W h e n m o n o c y t e s w e r e c u l t u r e d f o r 6 d, t h e n u m b e r
o f 3 C 1 0 b i n d i n g sites r o s e t o 1.8 x 105 p e r cell ( n o t shown).
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TABLE V

Competitionfor Ie~I-3C10 Binding by Unlabeled Antibodies
Unlabeled antibody

Mean cpm
minus background

Percent binding
comparedto no
unlabeledantibody

No unlabeled antibody
11,258
9.3F 10 (anti-la)
10.715
95
1E8 (antigranulocyte monocyte)
10,737
95
T29/33 (antileukocyte)
11,312
100
1B4 (anti-Csb~receptor)
15,510
138
1D9 (antimonocyte)
956
8
3C 10 (antimonocyte)
135
1
3G8 Fab (anti-Fc 3"receptor)
10,751
95
3C 10 Fab (antimonocyte)
1,085
10
L~Sl-3C10(1 #g/ml) was added to 4 x 105 monocytesthat previouslyhad
been exposed for 60 rain to either no other antibody, or to saturating
levels (50 vg/ml for all except T29/33, which was 1:100 dilution of
ascites) of several noniodinated monoclonalantibodies.
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Quantitative binding studies (not shown) established that the molecule carrying
the 3C10 antigen was sensitive to trypsin, pronase, and chymotrypsin but not to
neuraminidase. T h e 9.3F10 Ia-like determinant was not protease sensitive.
Binding of 125I-3C10 was blocked by cold 1D9 or cold 3C10 Fab (Table V).
However, all the other antibodies in our panel (Table 1), which included several
antibodies to HLA-class I and II antigens did not inhibit 3C 10 binding (see Table
V). We conclude that 3C10 and 1D9 bind to a similar, n o n - H L A determinant,
and that binding is not Fc mediated.
Identification of Polypeptides Bearing the 3C10, ID9, and 9.3FI0 Antigens. 3C10
precipitated a major 55 kD polypeptide from monocytes that had been surface
radiolabeled with Na-12~I and lactoperoxidase-glucose oxidase (Fig. 2, left). T h e
same polypeptide was identified with 3C 10 Fab. As anticipated, 9.3F 10 reacted
with a 33-29 kD doublet typical of the alpha and beta chains of HLA-class II
products (Fig. 2).
By Western blotting, 3C10 (Fig. 2, right) and 1D9 (not shown) again reacted
with a 55 kD polypeptide. In some blots, a minor 53 kD band reacted with 3C10.
This might have represented an intracellular precursor for the 55 kD 3C10
surface polypeptide (Fig. 2, right).
Use of Antimonocyte Antibodies in the Purification of Dendritic Cells. Although
blood dendritic cells adhere to plastic, they are far o u t n u m b e r e d by monocytes
(~20-fold) and lymphocytes. We first noted that 3C10 (antimonocyte), BA-1
(anti-B cell), and Leu-1 (anti-T cell) efficiently killed populations enriched in
monocytes, B cells, and T cells, respectively, but not dendritic cells (not shown).
We therefore devised a procedure (see Materials and Methods) in which monocyte-depleted adherent cells were prepared, cultured overnight, and reexposed
to complement and a battery of monoclonals: 3CI0, BA-1, and Leu-1. 80% of
the cells that survived cytolysis could be floated free from the dead cells on dense
albumin columns. T h e recovery was 0.1-0.2% of the total starting mononuclear
cells. By cytology (Fig. 3, a-c), ~ 7 0 % of the final low density population were
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dendritic cells, and total yield was comparable to controls that had been exposed
to complement only (Table VI). T h e dendritic cell fraction contained < 1 - 4 %
monocytes, identified by cytology or nonspecific esterase staining. Likewise B
and T cells were depleted to <2%, as monitored by immunofluorescence with
anti-Ig and Leu-2a and -3a antibodies. Controls exposed to complement in the
absence of antibodies were ,-,70% monocytes (Table VI, Fig. 3d). Therefore,
dendritic cells in blood (---,0.5% of total mononuclear cells) can be purified by a
technique that uses their adherence property and the fact that they lack the
differentiation markers of other cell types.
Distribution of Macrophages in Tissue Sections. Since 3C10 reacted with all
monocytes and alveolar macrophages, but not with dendritic cells, this antibody
was used to outline the distribution of macrophages in frozen sections of spleen,
lymph node, and skin. In spleen, both 3C 10 and 3C 10 Fab stained large numbers
of macrophages in the red pulp (Fig. 4). Lymphocytes in white pulp, fibroblasts
in connective tissue trabeculae, and endothelial and smooth muscle cells of blood
vessel walls were not stained. White pulp nodules, which probably contained
most of the dendritic cells (34, 35), had few 3C10 + cells in either T (Figs. 4, 5)
or B (not shown) regions. Some 3C 10 ÷ cells, presumably macrophages, abutted
the central white pulp arteries (Fig. 5). Leu- 1 stained collections o f t lymphocytes
close to the central arteries (Figs. 4, 5) as well as scattered cells in both red pulp
(Fig. 4) and B cell follicles (not shown). The anti-Ia antibody, 9.3F10, stained
both red and white pulp intensely. Ia ÷ cells in T-dependent areas probably
corresponded to dendritic or interdigitating cells (see Discussion) and far outnumbered 3C 10 + macrophages (Fig. 5).
In node (Fig. 6), 3C 10 ÷ cells were abundant along all of the lymphatic channels.
This included the subcapsular sinus into which afferent lymphatics empty; the
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FIGURE 2. Immunoprecipitation (left)and immunoblotting (right)analysis of the polypeptides
carrying the 3C10 and 9.3F 10 antigens. In the immunoprecipitation experiment, a radioiodinated monocyte lysate was precleared on Sepharose coupled to mouse Ig and then divided
into aliquots for precipitation with Sepharose coupled to 3C10 (antimonocyte), I E8 (antimonocyte, granulocyte), 9.3F10 (anti-class II), or mouse lg. The blotting experiment used directly
labeled 1~5I-3C10Ig at 0.08 ttg/ml, 7 × 108 cpm/~g; or an indirect approach (3C10 at 1 #g/
ml followedby J25I-F(ab)~rabbit anti-mouse Ig at 0.05 ttg/ml, 6 x 10° cpm/#g).
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FIGURE 3. Phase-contrast microscopy of low density adherent cells from blood. (a-c) Purified
dendritic cell fraction, prepared by cytolytic elimination of monocytes and lymphocytes as
described in Materials and Methods. Most of the cells exhibit the typical dendritic appearance
described previously (14). (d) Control low density population exposed to complement only;
most of the ceils have the characteristic features of monocytes, while ~ 10% are dendritic ceils
(arrow). (a) x 750, (b) x 1100, (c) × 750, (d) x 700.
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TABLE V I

Preparation of Human Dendritic Cells by Eliminating Other Cell Types with Monoclonal
Antibodies and Complement
Treatment

Starting number of mononuclear cells

Number oflowdensity adherent cells

Differential count of low-density
fractions
DC

Monocytes

Lymphs

%
Experiment 1
Complement only
Complement + 3C10

1.4 X 106
5 X 105

8
43

80
I

12
57

1.5 X 10 a
3.5 X 108

7 X 106
6 X 105

7
76

62
1

31
23

1 × 10 a
5 × 10 s

4.6 x 106
5 x 105

12
80

71
1

17
20

Experiment 2
Complement only
Complement + antibodies
(3C10 + BA-I + Leu-1)

Experiment 3
Complement only
Complement + antibodies
(3C10 + BA-1 + Leu-1)

Mononuclear cells were obtained from FicolI-Hypaque columns and processed, as described in
Materials and Methods, to deplete the adherent fraction of monocytes. T h e n the adherent cells that
came off the plastic surface after overnight culture were treated again with complement with or
without monoclonal antibodies as indicated. T h e cells resistant to cytolysis were recovered on albumin
columns (low-density adherent cells) and analyzed by phase-contrast microscopy. Round cells were
classified as ~lymphocytes" since they did not look like dendritic cells (DC) or monocytes; however
the BA-1- and Leu-l-treated populations lacked typical B and T cells by surface markers (see Results).

intermediate sinuses that penetrate the cortex along connective tissue trabeculae;
and the medullary cords that contain the efferent lymphatics. BC10 reactivity
was also noted in the center of secondary follicles (germinal centers; not shown).
However, 3C10 + cells were scarce in thymus-dependent regions (identified by
abundant Leu-l-positive T cells, and the presence of postcapillary venules) and
in follicular collections of small B cells (Fig. 6).
In normal skin (not shown), a few 3C10 + cells were scattered in the dermis. In
epidermis, Langerhans' cells were stained with OKT 6 (25), T 2 9 / 3 3 (antileukocyte) (21), and 9.3F10 (anti-Ia) reagents, but not with 3C10. Skin biopsies
were also studied from patients with lepromatous leprosy (Fig. 7), since these
contain macrophage-rich dermal infiltrates and in many cases, abundant epidermal Langerhans' cells (33). The infiltrates contained many 3C 10 ÷ cells, but again
epidermal Langerbans' cells failed to stain with 3C 10 (Fig. 7).
We conclude that 3C10 identifies mononuclear phagocytes that are resident
in dermis, lymph node, and spleen, and that migrate into inflammatory foci. Few
macrophages are noted in those regions considered to be rich in dendritic cells;
that is, the two cell types are segregated anatomically.
Discussion
We have described an antigen that is widely distributed on human mononuclear
phagocytes. The antigen is detected by the monoclonal antibodies, 3C10 and
1D9, and is present on most if not all blood monocytes, alveolar macrophages,
and macrophages in sections of skin, lymph node, and spleen. 5C10 and 1D9
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probably recognize a related if not identical antigen. Specifically, the reagents
compete for binding to monocytes and immunoprecipitate a similar 55 kD surface
molecule. In both binding and immunoprecipitation assays, 3C10 Fab behaves
identically to intact Ig (Tables IV, V, Fig. 2). This is important since monocytes
exhibit Fc receptors, which have a molecular weight o f "~55,000 (16, 20). T h e
3C10-1D9 antigen is clearly distinct from HLA-class II or Ia-like determinants
which in this paper were identified primarily with a new monoclonal, 9.3F10
(Tables I I - I V , Fig. 2). O f the many antimonocyte antibodies that have been
p r o d u c e d , 3C 10 and 1D9 most closely resemble the anti-Mo2 reagents described
by T o d d et al. (7, 10).
Use of Antimonocyte Antibodies in the Purification of Dendritic Cells. T h e 3C10
and ID9 antibodies do not stain (Table II) or kill dendritic cells enriched as
described previously (14). In fact elimination o f monocytes with 3C 10 antibody
and rabbit c o m p l e m e n t can be used to enrich dendritic cells in considerable
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FIGURE 4. Immunocytochemistry of the junction (dotted line) of red and white pulp in
spleen. Adjacent sections were stained with no primary antibody (a); 3C10 antimacrophage
(b); and Leu-1 anti-T cell (c). The red pulp contains some opaque profiles (a) which represent
background staining occurring in the absence of primary antibody. The red pulp has many
3C10÷ macrophages (b, arrows) and scattered T cells (c). The white pulp nodule, with central
arteries (arrowheads), contains an area rich in Leu-I ÷ cells (T area) that lacks 3C10÷ cells.
x 200.
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purity and yield (Table VI, Fig. 3). The enriched fractions that can be depleted
of B and T cells, with BA-1 and Leu-1 antibodies, contain 65-80% dendritic
cells. The identity of the remaining 20-35% is unclear but could include dendritic
cells that do not spread well at the time of assay. In the accompanying paper
(36), we also show that heterogeneous cell mixtures can be separated into 1D9 ÷
and 1D9- fractions; the former are highly enriched in monocytes and the latter
contain the dendritic cells.
The availability of the 3C10-1D9 antibodies is particularly timely, since the
separation of dendritic cells from mononuclear phagocytes in man (14) is more
demanding than in mouse (12). In both species, dendritic cells adhere to plastic
and account for <1% of total nucleated cells. However, human blood contains
large numbers of adherent monocytes (55-30%); mouse lymphoid tissues release
< 5 - 2 % adherent macrophages. Both monocytes and dendritic cells in man have
a low buoyant density; in mouse, most (,--2/3) dendritic cells float on dense
albumin columns, whereas most macrophages typically pellet. These experimental difficulties can be overcome by using 3C10 and 1D9 to identify and separate
the two cell types (Tables II, VI, Fig. 3). The experiments described here
represent the first time that antimacrophage antibodies have been used in the
purification of dendritic cells.
Distribution of Macrophages and Dendritic Celts in Tissues. Both 3C10 and its
Fab fragment are effective for immunocytochemical staining of tissue sections.
Endothelial cells, fibroblasts, lymphocytes, and dendritic cells do not stain with
3C10, but many 3C10 ÷ cells are found in regions that are known to be rich in
macrophages: the red pulp of spleen; the areas surrounding lymphatic vessels in
lymph node capsule, cortex, and medulla; and the dermal inflammatory infiltrates
of leprosy (Figs. 4-7). Since we have not used two macrophage labels simulta-
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FIGURE 5. Immunocytochemistry of the periarterial region of splenic white pulp. Adjacent
sections were stained with 9.3F 10 anti-Ia (left), 3C I 0 antimacrophage (middle), and Leu-1 antiT cell (right). The sections illustrate that the T area has few macrophages but many la ÷ cells.
The latter probably include interdigitating or dendritic cells (see Discussion). x 200.
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neously, we cannot be certain that all tissue macrophages stain with 3C10.
However, the staining is prominent, and the number of reactive cells is abundant.
It seems likely that 3C10 acts as a panmacrophage reagent in the tissues we have
studied.
Strikingly, 3C 10 + cells are not found in several compartments that are thought
to be rich in dendritic cells: white pulp of spleen, cortical lymphatic tissue of
node, and epidermis (Figs. 4-7). Staining with 3C 10 therefore reveals that most
macrophages and dendritic cells are segregated from one another, a distinction
that has never been so dramatically evident. In mouse spleen, dendritic cells can
be isolated from white but not red pulp (34), and can be visualized by electron
microscopy in white pulp (35). The white pulp dendritic cells resemble the
"interdigitating cells" (37, 38) first described by Veldman. Interdigitating cells
are concentrated in thymus-dependent regions of lymphoid organs in all mammals. Several studies have likened interdigitating cells in tissue sections to
dendritic cells isolated in vitro (39, reviewed in 40). In epidermis, Langerhans'
cells are stellate, bone marrow-derived, and Ia + (reviewed in 41). Human Langerhans' cells, identified in this study by their reactivity with anti-Ia, antileukocyte, and O K T 6 antibodies, are 3C 10-; likewise mouse epidermal Langer-
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FIGURE 6. lmmunocytochemistry of lymph node cortex. Adjacent sections were stained with
Leu-1, anti-Z cell (left) and 3C10, antimacrophage (right). Lymph node cortex contains two
kinds of lymphatic tissue: one is rich in Leu-1 ÷ T cells (T) and contains many postcapillary
venules (I0; the other contains follicles of Leu-1- B cells (F). Penetrating the cortex are
connective tissue trabeculae (X) that course from subcapsular cortex to the hilum. T h e
trabeculae are lined with lymphatic channels (not evident in frozen sections) and sheets of
3C10 + macrophages (region with dotted line), x 160.
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hans' ceils do not react with the F4/80, mac-l, and 2.4G2 monoclonals (Witmer
and Steinman, unpublished results), each of which binds to macrophages but not
to dendritic cells (2). Therefore Langerhans' cells, which frequently are likened
to macrophages, may be part of the dendritic cell system.
The segregation of macrophages and dendritic cells in spleen and lymph node
seems appropriate for the two main functions performed by lymphoid organs-clearance of antigen, and development of immune responses. The macrophage
is the "versatile element of inflammation" (42). It is endowed with endocytic and
microbicidal capacities, and these functions are enhanced by the Ig and lymphokine products of stimulated iymphocytes. Macrophages are concentrated in those
regions where antigen first leaves vascular and lymphatic channels, namely the
red pulp of spleen and the lymphatic sinuses of node. Therefore, macrophages
are positioned to scavenge and clear antigen, and likely constitute a major first
line of host defense. In contrast, dendritic cells are "nature's adjuvant," the
principal accessory cell required for the stimulation of many lymphocyte responses (13). Dendritic cells likely are poised near recirculating lymphocytes, and
are accessible to antigen that escapes macrophage clearance. Although additional
immunocytochemical studies of antigen-stimulated tissues are needed, during
immune responses lymphoblasts first develop in regions that are macrophage
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FIGURE 7. lmmunocytochemistry of a skin biopsy from a patient with lepromatous leprosy.
Adjacent sections were stained with OKT6, anti-Langerhans' cell (left) and 3C10, antimacrophage (right). A network of Langerhans' cell processes is evident in the epidermis, but this
network lacks the 3C 10 determinant. In contrast, the dermal infiltrates of leprosy represent a
dense network of 3C 10 + O KT6- macrophages, and (not shown) OKT 8*4- lymphocytes (33).
Although Langerhans' cells can increase in number in leprosy epidermis (33), their surface
markers (OKT6 +, 3C10-, Ia ÷) are comparable to normal skin. x 160.
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poor and dendritic cell rich (see 43-46). These anatomical findings are an
important adjunct to in vitro studies that compare the accessory function of
human macrophages and dendritic cells. The latter are the subject of the
accompanying paper (36).

Received for publication 16 March 1983.
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